Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00804427Not ApplicableCompleted

Effect of Fish Oil on Plasma Triglycerides in Adults

Role: collaborator

NCT01178892Not ApplicableCompleted

MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation

Role: collaborator

NCT01666392Not ApplicableWithdrawn

Omega-3 Fatty Acid Supplementation in Older Adults

Role: collaborator

NCT01213342Not ApplicableTerminated

Omega-3 Fatty Acid Supplements and Dry Eye

Role: collaborator

All 4 trials loaded